Beranda › Diabetes Tipe 2 › Connecticut
Uji klinis Diabetes Tipe 2 di Connecticut
14 studi untuk Diabetes Tipe 2 mencari peserta di lokasi di Connecticut.
Kota di Connecticut
Teks studi resmi (Bahasa Inggris)
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Chase Medical Research LLC, Waterbury
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07817251EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Cardiology Physicians of Fairfield County - Bridgeport, Bridgeport
- CMR of Greater New Haven, LLC, Hamden
- Cardiology Associates of Fairfield County, Stamford
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07064473A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- New England Research Associates, LLC, Bridgeport
- CMR of Greater New Haven, LLC, Hamden
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07282600Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Yale University, New Haven
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Bridgeport
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Yale School of Medicine, New Haven
Menerima pesertaFase 3
Usia 10 hingga 18 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07282613A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Bridgeport
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT07662044A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Yale Diabetes Research, New Haven
Menerima pesertaFase 3
Usia 10 hingga 17 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06739122Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Yale, New Haven
Menerima peserta
Usia 14 hingga 75 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT07579702Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life
- Yale University, New Haven
Menerima pesertaSukarelawan sehat diterima
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT07376655Ultrasound Effects on Glycemic Control in T2DM
- Yale-New Haven Hospital, New Haven
Menerima peserta
Usia 21 hingga 75 · Semua jenis kelamin · Diperbarui 27 Jan 2026 · NCT05354947Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access
- Fair Haven Community Health Care (FHCHC), New Haven
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Des 2025 · NCT06658067Diabetes Learning in Virtual Environments Just in Time for Community Reentry
- University of Connecticut, Storrs
- University of Connecticut, Storrs Mansfield
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Jul 2025 · NCT05286892Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)
- Yale New Haven Hospital (YNHH) Research Unit (HRU), New Haven
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 14 Jan 2025 · NCT05776563Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.